en · de · es · pt
cjc-1295-notes.peptides3081.com › Guide › Molecular Background And Naming — Practical Notes

Molecular Background And Naming — Practical Notes

By Editorial Desk · published 2026-01-17 · last reviewed 2026-02-25 · Guide

Everything below concerns lyophilized powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-02-25. Numbers and descriptions here follow the published literature rather than marketing material.

Molecular Background and Naming

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

Analytical Measurement And Stability

Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.

Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight (no linker)~3.37 kDaCalculated from peptide sequence
Molecular weight (with linker)~3.65 kDaIncludes albumin-binding moiety
AppearanceWhite to off-white powderTypically lyophilized
SolubilitySoluble in waterAlso dissolves in aqueous buffers
Common synonymsModified GRF(1-29), DAC:GRFUsage varies by source

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

Related pages on this site

CJC-1295 Background and Mechanism

The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.

Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.

Further detail

Having broadcast on talkSPORT from 2006 to 2012, Galloway began to broadcast on talkRADIO (which launched in March 2016 as a sister station to Talksport) in June 2016. Amongst his many monologues, he said that if Scotland were to leave the UK and join the EU "it would not be a good thing for his fellow countrymen", and has condemned the BBC as a "national disgrace". In June 2019, after Liverpool Football Club had defeated Tottenham Hotspur Football Club in the Champions League final, Galloway congratulated the people of Liverpool and tweeted "No #Israël [sic] flags on the Cup!". He said that this referred to a number of Tottenham fans who were flying the flag of Israel in the crowd, showing "an affiliation to a 'racist state'". Tottenham Hotspur accused Galloway of "blatant anti-Semitism" and talkRADIO sacked him saying the broadcaster "does not tolerate anti-Semitic views".

Jellyfish is very low in cholesterol and sugars, but cheap preparation can introduce undesirable amounts of heavy metals. The "sea wasp" Chironex fleckeri has been described as the world's most venomous jellyfish and is held responsible for 67 deaths, although it is difficult to identify the animal as it is almost transparent. Most stingings by C. fleckeri cause only mild symptoms. Seven other box jellies can cause a set of symptoms called Irukandji syndrome, which takes about 30 minutes to develop, and from a few hours to two weeks to disappear. Hospital treatment is usually required, and there have been a few deaths. A number of the parasitic myxozoans are commercially important pathogens in salmonid aquaculture. A Scyphozoa species – Pelagia noctiluca – and a Hydrozoa – Muggiaea atlantica – have caused repeated mass mortality in salmon farms over the years around Ireland. A loss valued at £1 million struck in November 2007, 20,000 died off Clare Island in 2013 and four fish farms collectively lost tens of thousands of salmon in September 2017.

=== Borealis === Shortly before his departure from Valve in 2016, Laidlaw led a virtual reality (VR) project on the Source 2 engine, Borealis, set on the time-travelling ship mentioned in Episode Two and Portal 2. The game would skip between the Combine's conquering of Earth before Half-Life 2 and a time set shortly after Episode Two. A minigame in which players would fish off the bow of the ship was also proposed. Laidlaw said the project ended because it was too early to be working in VR: "When people are struggling with the basic tools they need to rough out a concept, it's hard to convey any sort of vision, and it all evaporated pretty quickly."

== External links == "Ghrelin Receptor". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2015-07-11. Retrieved 2007-10-25. growth+hormone+secretagogue+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Ghrelin Archived 2008-05-12 at the Wayback Machine at Colorado State University This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Sources: en.wikipedia.org

Supporting material

Cu2+ + 2 e− → Cu (cathode), E°cell = 0.34 V Copper sulfate is commonly included in teenage chemistry sets and undergraduate experiments. It is often used to grow crystals in schools and in Copper electroplating experiments despite its toxicity. Copper sulfate is often used to demonstrate an exothermic reaction, in which steel wool or magnesium ribbon is placed in an aqueous solution of CuSO4. It is used to demonstrate the principle of mineral hydration. The pentahydrate form, which is blue, is heated, turning the copper sulfate into the anhydrous form which is white, while the water that was present in the pentahydrate form evaporates. When water is then added to the anhydrous compound, it turns back into the pentahydrate form, regaining its blue color. Copper(II) sulfate pentahydrate can easily be produced by crystallization from solution as copper(II) sulfate, which is hygroscopic.

== Bacteriophage T4 DNA polymerase == Bacteriophage (phage) T4 gene 43 encodes the phage's DNA polymerase replicative enzyme. Temperature-sensitive (ts) gene 43 mutants have been identified that have an antimutator phenotype, that is a lower rate of spontaneous mutation than wild type. Studies of one of these mutants, tsB120, showed that the DNA polymerase specified by this mutant copies DNA templates at a slower rate than the wild-type polymerase. However, the 3' to 5' exonuclease activity was no higher than wild-type. During DNA replication the ratio of nucleotides turned over to those stably incorporated into newly formed DNA is 10 to 100 times higher in the case of the tsB120 mutant than in wild-type. It was proposed that the antimutator effect may be explained by both greater accuracy in nucleotide selection and an increased efficiency of removal of noncomplementary nucleotides (proofreading) by the tsB120 polymerase. When phage T4 virions with a wild-type gene 43 DNA polymerase are exposed to either ultraviolet light, which introduces cyclobutane pyrimidine dimer damages in DNA, or psoralen-plus-light, which introduces pyrimidine adducts, the rate of mutation increases. However, these mutagenic effects are inhibited when the phage's DNA synthesis is catalyzed by the tsCB120 antimutator polymerase, or another antimutator polymerase, tsCB87. These findings indicate that the level of induction of mutations by DNA damage can be strongly influenced by the gene 43 DNA polymerase proofreading function.

== Evolutionary history == It was found that pyruvate dehydrogenase enzyme found in the mitochondria of eukaryotic cells closely resembles an enzyme from Geobacillus stearothermophilus, which is a species of gram-positive bacteria. Despite similarities of the pyruvate dehydrogenase complex with gram-positive bacteria, there is little resemblance with those of gram-negative bacteria. Similarities of the quaternary structures between pyruvate dehydrogenase and enzymes in gram-positive bacteria point to a shared evolutionary history which is distinctive from the evolutionary history of corresponding enzymes found in gram-negative bacteria. Through an endosymbiotic event, pyruvate dehydrogenase found in the eukaryotic mitochondria points to ancestral linkages dating back to gram-positive bacteria. Pyruvate dehydrogenase complexes share many similarities with branched chain 2-oxoacid dehydrogenase (BCOADH), particularly in their substrate specificity for alpha-keto acids. Specifically, BCOADH catalyzes the degradation of amino acids and these enzymes would have been prevalent during the periods on prehistoric Earth dominated by rich amino acid environments. The E2 subunit from pyruvate dehydrogenase evolved from the E2 gene found in BCOADH while both enzymes contain identical E3 subunits due to the presence of only one E3 gene. Since the E1 subunits have a distinctive specificity for particular substrates, the E1 subunits of pyruvate dehydrogenase and BCOADH vary but share genetic similarities.

== History == It was published in 1950 by Blakiston. Creator and editor Tinsley Harrison's quotation appeared on the first edition of this book in 1950: No greater opportunity or obligation can fall the lot of a human being than to be a physician. In the care of suffering he needs technical skill, scientific knowledge and human understanding. He who uses these with courage, humility and wisdom will provide a unique service to his fellow man and will build an enduring edifice of character within himself. The physician should ask of his destiny no more than this and he should be content with no less. Blakiston was acquired by McGraw-Hill in 1954. The 17th edition of the textbook is dedicated to George W. Thorn, who was editor of the first seven editions of the book and editor in chief of the eighth edition. He died in 2004. The 18th edition of the book (ISBN 978-0071748896) was edited by Anthony Fauci, Dennis Kasper, Stephen Hauser, J. Larry Jameson and Joseph Loscalzo. New chapters added include "Systems Biology in Health and Disease," "The Human Microbiome," "The Biology of Aging," and "Neuropsychiatric Illnesses in War Veterans." The 19th edition of the book was edited by Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson and Joseph Loscalzo. AL.com in December 2014 wrote that it was still "a best-selling internal medicine text in the United States and around the world," and that it had been reprinted 16 times and translated into 14 languages. The 20th edition of the book, edited by Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J.

=== Cancer === In 2015, the International Agency for Research on Cancer (IARC) classified unprocessed red meat as "probably carcinogenic to humans (Group 2A)". To make this classification, the IARC Working Group assessed over 800 epidemiological studies in addition to other types of studies such as animal bioassays. When assessing whether substances are carcinogenic to humans, it is rare for data from randomized trials to be available. The Working Group found "limited" epidemiological evidence linking unprocessed red meat to colorectal, pancreatic, and prostate cancer. Additionally, it found "strong mechanistic evidence" that unprocessed red meat is carcinogenic. Mechanistic evidence is evidence of plausible biological pathways in which a substance could cause cancer. For instance, studies had found that participants who had recently eaten red meat had higher levels of carcinogenic N-nitroso compounds in their guts and feces. For processed red meat, evidence of harm is stronger. The IARC classified processed meat as carcinogenic to humans (Group 1), based on "sufficient evidence in humans that the consumption of processed meat causes colorectal cancer." The American Institute for Cancer Research, Cancer Research UK and World Cancer Research Fund International have supported these conclusions. More recent meta-analyses have further supported the finding that high consumption of red meat is associated with increased risk of gastrointestinal cancer.

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Why do two versions share one name?

Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.

What is the relationship to GRF(1-29)?

The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.

How are the two variants distinguished in a laboratory?

The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.

Network